These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18262039

  • 1. Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study.
    Mouton R, Finch D, Davies I, Binks A, Zacharowski K.
    Lancet; 2008 Feb 09; 371(9611):475-82. PubMed ID: 18262039
    [Abstract] [Full Text] [Related]

  • 2. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND.
    Ann Thorac Surg; 2005 Oct 09; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [Abstract] [Full Text] [Related]

  • 3. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT.
    Am J Nephrol; 2008 Oct 09; 28(4):576-82. PubMed ID: 18264006
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M.
    Eur J Cardiothorac Surg; 2005 Oct 09; 28(4):563-8. PubMed ID: 16125959
    [Abstract] [Full Text] [Related]

  • 5. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z, Shopen Y, Alon H, Cohen O, Nir RR, Adler Z, Bolotin G.
    J Thorac Cardiovasc Surg; 2013 Jan 09; 145(1):243-8. PubMed ID: 23072702
    [Abstract] [Full Text] [Related]

  • 6. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
    Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J, Investigators of The Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation.
    JAMA; 2007 Feb 07; 297(5):471-9. PubMed ID: 17284697
    [Abstract] [Full Text] [Related]

  • 7. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb 07; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 8. Aprotinin--still courting controversy.
    Hausenloy DJ, Pagano D, Keogh B.
    Lancet; 2008 Feb 09; 371(9611):449-50. PubMed ID: 18262023
    [No Abstract] [Full Text] [Related]

  • 9. The risk associated with aprotinin in cardiac surgery.
    Mangano DT, Tudor IC, Dietzel C, Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation.
    N Engl J Med; 2006 Jan 26; 354(4):353-65. PubMed ID: 16436767
    [Abstract] [Full Text] [Related]

  • 10. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB, Lemke J, Lange M, Rastan A, Mohr FW.
    Ann Thorac Surg; 2008 May 26; 85(5):1662-8. PubMed ID: 18442562
    [Abstract] [Full Text] [Related]

  • 11. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.
    Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626
    [Abstract] [Full Text] [Related]

  • 12. [Control of postoperative hemorrhage in isolated coronary bypass surgery: comparison of tranexamic acid effects in off-pump surgery with aprotinin effects in conventional surgery].
    Bordalo AD, Nobre AL, Silva F, Serpa C, Cravino J.
    Rev Port Cir Cardiotorac Vasc; 2011 Jan 01; 18(3):143-8. PubMed ID: 23596616
    [Abstract] [Full Text] [Related]

  • 13. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF.
    N Engl J Med; 2008 Feb 21; 358(8):784-93. PubMed ID: 18287601
    [Abstract] [Full Text] [Related]

  • 14. Renal dysfunction in cardiac surgery: identifying potential risk factors.
    Barnum JL, Sistino JJ.
    Perfusion; 2009 Mar 21; 24(2):139-42. PubMed ID: 19654159
    [Abstract] [Full Text] [Related]

  • 15. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 21; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 16. Aprotinin-associated risks in off-pump coronary artery bypass grafting.
    Bittner HB, Lange M, Lemke J, Rastan A, Mohr FW.
    Thorac Cardiovasc Surg; 2009 Dec 21; 57(8):455-9. PubMed ID: 20013617
    [Abstract] [Full Text] [Related]

  • 17. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A, Jooste EH, Kuch BA, Lichtenstein SE, Morell V, Munoz R, Ellis D, Davis PJ.
    Anesth Analg; 2009 Jul 21; 109(1):45-52. PubMed ID: 19535694
    [Abstract] [Full Text] [Related]

  • 18. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
    Riddell RE, Buth KJ, Sullivan JA.
    Can J Anaesth; 2013 Jan 21; 60(1):16-23. PubMed ID: 23132043
    [Abstract] [Full Text] [Related]

  • 19. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A, Sápi E, Breuer T, Kertai MD, Bodor G, Vargha P, Szatmári A.
    Paediatr Anaesth; 2008 Feb 21; 18(2):151-9. PubMed ID: 18184247
    [Abstract] [Full Text] [Related]

  • 20. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ, Griesdale DE, Schneeweiss S.
    Pharmacoepidemiol Drug Saf; 2009 Apr 21; 18(4):259-68. PubMed ID: 19185048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.